Distinct mutation profiles between primary bladder cancer and circulating tumor cells warrant the use of circulating tumors cells as cellular resource for mutation follow-upTae‐Min Kim(Harvard University), U‐Syn Ha(St. Mary's Hospital)BMC CancerDecember 1, 202010.1186/s12885-020-07684-6Cited by 8SaveCiteExport RISWatch citationsRelated PapersGene Expression Analysis Reveals the Cell Cycle and Kinetochore Genes Participating in Ischemia Reperfusion Injury and Early Development in Kidney|PLoS ONE|2011|12